Relative absolute values of the miRNA species are provided for comparison to each other coming from the bioreactor with and without MDA-231 cells. Figure S2. Relative absolute values of the miRNA species are provided for comparison to each other coming from the MDA-231 cells in 3D tissue versus 2D. Figure S3. A upper panel: Experimental outline for cell cycle analysis. A lower panel: Cell cycle analysis, using Propidium Iodide, of 2D co-culture experiments, following priming of the hepatic niche with cancer derived exosomes. B: miRNA content of exosomes derived from the HepN in the Liver MPS. C: IPA analysis of the miRNA content in the exosomes described above. Figure S4. Relative absolute values of the miRNA species are provided for compar...
Figure S3. Exosome-mediated transfer of miR-193a, miR-210-3p and miR-5100 from BMSCs promotes invasi...
miR-32-5p does not affect apoptosis. (A) Flow cytometric analysis of apoptosis rate in Bel7402 cells...
Additional file 1: Supplementary Figure S1. Exosomes derived from CD133+ cells enhance the malignant...
Figure S7. Exosomal miRNA-21 activates HSCs via PTEN/PDK1/AKT signaling axis. Immunofluorescence ass...
Figure S1. Identifying exosomal miRNAs secreted from hypoxic BMSCs. LLC cells that were stably trans...
Biogenesis pathway and subcellular localization of miRs. miRs are mainly transcribed by RNA pol II, ...
Figure S1. Particles isolated from CCM by ExoQuick were identified by TEM, western blot and NTA. (A)...
(a) Characterization of isolated exosomes. Left panel: DSL for exosomes released by SKHep Middle pan...
The representative image of ISH showing the miR-200c blue chromogenic signal in the cytoplasmic regi...
Figure S2. Tumor-derived exosomes activated HSCs in vitro. a Flow cytometry assays of cell cycle sho...
Table S1. Sequences of primers and miRNA-inhibitor/mimic used in the study. (DOCX 14 kb
Figure S3. Tumor-derived exosomes activated HSCs in vivo. a Immunofluorescence imaging showed the de...
Figure S1. Exosome characterization by TEM and Western blot. TEM images of exosomes derived from BC ...
Figure S4. Tumor-derived exosomes activated HSCs in vivo. a Immunohistochemistry imaging of Ki67 sho...
Expression level of miR-222-3p was detected in A549-P/GR cells and A549-P-KD cells after co-incubati...
Figure S3. Exosome-mediated transfer of miR-193a, miR-210-3p and miR-5100 from BMSCs promotes invasi...
miR-32-5p does not affect apoptosis. (A) Flow cytometric analysis of apoptosis rate in Bel7402 cells...
Additional file 1: Supplementary Figure S1. Exosomes derived from CD133+ cells enhance the malignant...
Figure S7. Exosomal miRNA-21 activates HSCs via PTEN/PDK1/AKT signaling axis. Immunofluorescence ass...
Figure S1. Identifying exosomal miRNAs secreted from hypoxic BMSCs. LLC cells that were stably trans...
Biogenesis pathway and subcellular localization of miRs. miRs are mainly transcribed by RNA pol II, ...
Figure S1. Particles isolated from CCM by ExoQuick were identified by TEM, western blot and NTA. (A)...
(a) Characterization of isolated exosomes. Left panel: DSL for exosomes released by SKHep Middle pan...
The representative image of ISH showing the miR-200c blue chromogenic signal in the cytoplasmic regi...
Figure S2. Tumor-derived exosomes activated HSCs in vitro. a Flow cytometry assays of cell cycle sho...
Table S1. Sequences of primers and miRNA-inhibitor/mimic used in the study. (DOCX 14 kb
Figure S3. Tumor-derived exosomes activated HSCs in vivo. a Immunofluorescence imaging showed the de...
Figure S1. Exosome characterization by TEM and Western blot. TEM images of exosomes derived from BC ...
Figure S4. Tumor-derived exosomes activated HSCs in vivo. a Immunohistochemistry imaging of Ki67 sho...
Expression level of miR-222-3p was detected in A549-P/GR cells and A549-P-KD cells after co-incubati...
Figure S3. Exosome-mediated transfer of miR-193a, miR-210-3p and miR-5100 from BMSCs promotes invasi...
miR-32-5p does not affect apoptosis. (A) Flow cytometric analysis of apoptosis rate in Bel7402 cells...
Additional file 1: Supplementary Figure S1. Exosomes derived from CD133+ cells enhance the malignant...